Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor

被引:244
作者
Niu, HF
Ye, BHH
Dalla-Favera, R [1 ]
机构
[1] Columbia Univ, Dept Pathol, New York, NY 10032 USA
[2] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA
关键词
BCL-6; BCR signaling; MAP kinase; POZ/zinc finger proteins; ubiquitin-proteasome;
D O I
10.1101/gad.12.13.1953
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The bcl-6 proto-oncogene encodes a POZ/zinc finger transcriptional repressor expressed in germinal center (GC) B and T cells and required for GC formation and antibody affinity maturation. Deregulation of bcl-6 expression by chromosomal rearrangements and point mutations of the bcl-6 promoter region are implicated in the pathogenesis of B-cell lymphoma. The signals regulating bcl-6 expression are not known. Here we show that antigen receptor activation leads to BCL-6 phosphorylation by mitogen-activated protein kinase (MAPK). Phosphorylation, in turn, targets BCL-6 for rapid degradation by the ubiquitin/proteasome pathway. These findings indicate that BCL-6 expression is directly controlled by the antigen receptor via MAPK activation. This signaling pathway may be crucial for the control of B-cell differentiation and antibody response and has implications for the regulation of other POZ/zinc finger transcription factors in other tissues.
引用
收藏
页码:1953 / 1961
页数:9
相关论文
共 57 条
[31]   Photoreceptor cell differentiation requires regulated proteolysis of the transcriptional repressor Tramtrack [J].
Li, SH ;
Li, Y ;
Carthew, RW ;
Lai, ZC .
CELL, 1997, 90 (03) :469-478
[32]   REARRANGEMENTS OF THE BCL6 GENE IN DIFFUSE LARGE-CELL NON-HODGKINS-LYMPHOMA [J].
LOCOCO, F ;
YE, BH ;
LISTA, F ;
CORRADINI, P ;
OFFIT, K ;
KNOWLES, DM ;
CHAGANTI, RSK ;
DALLAFAVERA, R .
BLOOD, 1994, 83 (07) :1757-1759
[33]   GERMINAL-CENTERS [J].
MACLENNAN, ICM .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :117-139
[34]   Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma [J].
Migliazza, A ;
Martinotti, S ;
Chen, WY ;
Fusco, C ;
Ye, BH ;
Knowles, DM ;
Offit, K ;
Chaganti, RSK ;
DallaFavera, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) :12520-12524
[35]  
MIKI T, 1994, BLOOD, V83, P26
[36]  
MINAMI Y, 1994, J IMMUNOL, V152, P5680
[37]   BCL-6 is phosphorylated at multiple sites in its serine- and proline-clustered region by mitogen-activated protein kinase (MAPK) in vivo [J].
Moriyama, M ;
Yamochi, T ;
Semba, K ;
Akiyama, T ;
Mori, S .
ONCOGENE, 1997, 14 (20) :2465-2474
[38]   BCL-6 GENE-PRODUCT, A 92-KD TO 98-KD NUCLEAR PHOSPHOPROTEIN, IS HIGHLY EXPRESSED IN GERMINAL CENTER B-CELLS AND THEIR NEOPLASTIC COUNTERPARTS [J].
ONIZUKA, T ;
MORIYAMA, M ;
YAMOCHI, T ;
KURODA, T ;
KAZAMA, A ;
KANAZAWA, N ;
SATO, K ;
KATO, T ;
OTA, H ;
MORI, S .
BLOOD, 1995, 86 (01) :28-37
[39]   ANALYSIS OF LAZ3 (BCL-6) STATUS IN B-CELL NON-HODGKINS-LYMPHOMAS - RESULTS OF REARRANGEMENT AND GENE-EXPRESSION STUDIES AND A MUTATIONAL ANALYSIS OF CODING REGION SEQUENCES [J].
OTSUKI, T ;
YANO, T ;
CLARK, HM ;
BASTARD, C ;
KERCKAERT, JP ;
JAFFE, ES ;
RAFFELD, M .
BLOOD, 1995, 85 (10) :2877-2884
[40]   ROLE OF THE UBIQUITIN-PROTEASOME PATHWAY IN REGULATING ABUNDANCE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27 [J].
PAGANO, M ;
TAM, SW ;
THEODORAS, AM ;
BEERROMERO, P ;
DELSAL, G ;
CHAU, V ;
YEW, PR ;
DRAETTA, GF ;
ROLFE, M .
SCIENCE, 1995, 269 (5224) :682-685